What is the appropriate treatment for a pleural effusion?

Treatment of Pleural Effusion

The treatment of pleural effusion is fundamentally determined by whether it is a transudate or exudate, with transudates managed by treating the underlying cause (heart failure, cirrhosis, nephrosis) and exudates requiring cause-specific therapy ranging from antibiotics for infection to drainage procedures for malignancy.

Initial Diagnostic Approach

The first critical step is performing diagnostic pleural aspiration with a 21G needle, sending fluid for protein, LDH, pH, Gram stain, AAFB stain, cytology, and culture in both sterile vials and blood culture bottles 1. Use ultrasound guidance for all pleural interventions to reduce pneumothorax risk from 39% historically to approximately 2% 2.

Transudate vs. Exudate Classification

• Apply Light's criteria when pleural fluid protein is 25-35 g/L 1
• If transudate: Treat the underlying cause (left ventricular failure, hypoalbuminemia, dialysis) 1
• If exudate: Proceed with cause-specific evaluation and treatment

Treatment by Etiology

Parapneumonic Effusion/Empyema

Key indicators requiring drainage include:

• Frank pus on aspiration
• Positive Gram stain
• pH <7.00
• Glucose <2.2 mmol/L (40 mg/dL)
• Pleural loculations
• LDH >3 times upper limit of normal 3

Treatment algorithm:

1. Insert small-bore chest tube (14-16 Fr) for drainage 4
2. If loculated or inadequate drainage: Administer intrapleural fibrinolytics (urokinase or alteplase) combined with DNase 4, 5
3. If fibrinolytics fail after 48-72 hours: Proceed to video-assisted thoracic surgery (VATS) or thoracotomy with decortication 4
4. Antibiotics for 2-6 weeks 5

Malignant Pleural Effusion

Do not perform interventions in asymptomatic patients 2.

For symptomatic patients with dyspnea:

Step 1: Assess Lung Expandability

Perform large-volume thoracentesis to determine if symptoms improve and if lung expands fully 2.

Step 2: Choose Definitive Management Based on Lung Expansion

If lung is expandable (no trapped lung):

• Either indwelling pleural catheter (IPC) OR chemical pleurodesis are equally acceptable first-line options 2
• For pleurodesis: Either talc poudrage (via thoracoscopy) OR talc slurry (4-5g in 50 mL saline via chest tube) are equally effective 6, 2, 7
• Talc slurry technique: Clamp tube for 1 hour, rotate patient, maintain on -20 cm H₂O suction, remove tube when drainage <100-150 mL/24h 6
• If drainage remains >250 mL/24h after 48-72 hours, repeat talc instillation 6

If lung is nonexpandable, failed pleurodesis, or loculated effusion:

• Use IPC instead of attempting pleurodesis 2
• IPC allows outpatient ambulatory management 7

Step 3: Consider Systemic Therapy

For chemotherapy-responsive tumors (small-cell lung cancer, breast cancer, lymphoma, ovarian, thyroid, germ-cell), initiate systemic therapy concurrently with local management 6.

IPC-Associated Infections

Treat with antibiotics through the catheter without removal; only remove catheter if infection fails to improve 2.

Tuberculous Effusion

Send pleural fluid for AAFB stain and TB culture 1. Consider pleural biopsy if fluid analysis nondiagnostic, as adenosine deaminase and gamma-interferon levels aid diagnosis 3.

Cardiac/Hepatic Hydrothorax (Refractory)

For heart failure-related effusions:

• First-line: Therapeutic thoracentesis
• If frequently needed: IPC placement 4

For hepatic hydrothorax:

• Repeated therapeutic thoracenteses while awaiting definitive management
• Avoid IPC if liver transplant candidate due to high infection risk that may jeopardize candidacy 4
• In non-transplant candidates: IPC is acceptable alternative to serial thoracenteses 4
• Consider transjugular intrahepatic portosystemic shunt (TIPS) as bridge to transplant 4

Common Pitfalls

• Never attempt pleurodesis with trapped lung—it will fail and cause unnecessary morbidity 6
• Do not use talc in patients at high risk as it causes ARDS in ~5% with 1% mortality 3
• Ensure complete lung expansion before pleurodesis—incomplete drainage leads to loculations and failure 6
• Do not delay drainage in infected effusions—mortality reaches 50% without prompt intervention 5
• Only 60% of malignant effusions are diagnosed by cytology alone; if negative with high suspicion, proceed directly to thoracoscopy with pleural biopsy 1